SCHEMBL7047830

SCHEMBL7047830

CC(C)N(CCNc1ccc(S(=O)(=O)Oc2ccc3[nH]c(NC(=O)C4CC4)nc3c2)cc1)C(C)C.O=C(Nc1nc2cc(OS(=O)(=O)c3ccc(NCCN4CCOCC4)cc3)ccc2[nH]1)C1CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38
KDM4E B2RXH2 2/20 0.38
ALDH1A1 P00352 2/20 0.38
GLA P06280 1/20 0.38
GAA P10253 1/20 0.38
JAK1 P23458 1/20 0.38
CASR P41180 2/20 0.37
AURKA O14965 1/20 0.37
AURKB Q96GD4 1/20 0.37
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37
TUBB2A Q13885 1/20 0.37
TUBB8 Q3ZCM7 1/20 0.37
TUBA3E Q6PEY2 1/20 0.37
TUBA1A Q71U36 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5036624 0.94 TSHR (0.43) TSHRKDM4EALDH1A1GLAGAA
SCHEMBL5040832 0.91 SMN1; SMN2 (0.42) ENPP3ENPP1ENPP2SMN1; SMN2ACR
SCHEMBL5033529 0.90 JAK1 (0.40) TSHRALDH1A1GLAJAK1TUBB4A
SCHEMBL5042839 0.88 ENPP3 (0.44) ENPP3ENPP1ENPP2SMN1; SMN2
SCHEMBL5033487 0.87 ENPP3 (0.45) ENPP3ENPP1ENPP2SMN1; SMN2
SCHEMBL5036324 0.86 SMN1; SMN2 (0.41) ENPP3ENPP1ENPP2MAPTSMN1; SMN2
SCHEMBL5040962 0.86 TSHR (0.45) TSHRKDM4EALDH1A1GLAGAA
SCHEMBL7049581 0.84 ENPP3 (0.43) ENPP3ENPP1ENPP2SMN1; SMN2
SCHEMBL5036884 0.84 SMN1; SMN2 (0.43) ENPP3ENPP1ENPP2SMN1; SMN2
SCHEMBL5037583 0.83 ENPP3 (0.43) ENPP3ENPP1ENPP2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432417-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2004-06-30 EP disclosed
WO-2003028721-A2 SUBSTITUTED BENZIMIDAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCER AVENTIS PHARMA S.A. (FR) 2003-04-10 WO disclosed